184 related articles for article (PubMed ID: 35872305)
1. Chronic hyperinsulinemia promotes human hepatocyte senescence.
Baboota RK; Spinelli R; Erlandsson MC; Brandao BB; Lino M; Yang H; Mardinoglu A; Bokarewa MI; Boucher J; Kahn CR; Smith U
Mol Metab; 2022 Oct; 64():101558. PubMed ID: 35872305
[TBL] [Abstract][Full Text] [Related]
2. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
3. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
4. Targeting senescent cells alleviates obesity-induced metabolic dysfunction.
Palmer AK; Xu M; Zhu Y; Pirtskhalava T; Weivoda MM; Hachfeld CM; Prata LG; van Dijk TH; Verkade E; Casaclang-Verzosa G; Johnson KO; Cubro H; Doornebal EJ; Ogrodnik M; Jurk D; Jensen MD; Chini EN; Miller JD; Matveyenko A; Stout MB; Schafer MJ; White TA; Hickson LJ; Demaria M; Garovic V; Grande J; Arriaga EA; Kuipers F; von Zglinicki T; LeBrasseur NK; Campisi J; Tchkonia T; Kirkland JL
Aging Cell; 2019 Jun; 18(3):e12950. PubMed ID: 30907060
[TBL] [Abstract][Full Text] [Related]
5. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.
Islam MT; Tuday E; Allen S; Kim J; Trott DW; Holland WL; Donato AJ; Lesniewski LA
Aging Cell; 2023 Feb; 22(2):e13767. PubMed ID: 36637079
[TBL] [Abstract][Full Text] [Related]
6. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
[TBL] [Abstract][Full Text] [Related]
7. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
8. Human Rotator Cuff Tears Reveal an Age-Dependent Increase in Markers of Cellular Senescence and Selective Removal of Senescent Cells With Dasatinib + Quercetin Increases Genetic Expression of COL1A1 In Vitro.
Hawthorne BC; Wellington IJ; Sabitsky JT; Murphy KV; Karsmarski OP; Thomas RO; LeVasseur MR; Mancini MR; Trudeau MT; Gulati S; McCarthy MBR; Cote MP; Xu M; Mazzocca AD
Arthroscopy; 2024 Jan; 40(1):34-44. PubMed ID: 37356505
[TBL] [Abstract][Full Text] [Related]
9. Combined use of dasatinib and quercetin alleviates overtraining-induced deficits in learning and memory through eliminating senescent cells and reducing apoptotic cells in rat hippocampus.
Wang C; Kang Y; Liu P; Liu W; Chen W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Behav Brain Res; 2023 Feb; 440():114260. PubMed ID: 36535433
[TBL] [Abstract][Full Text] [Related]
10. Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice.
Saccon TD; Nagpal R; Yadav H; Cavalcante MB; Nunes ADC; Schneider A; Gesing A; Hughes B; Yousefzadeh M; Tchkonia T; Kirkland JL; Niedernhofer LJ; Robbins PD; Masternak MM
J Gerontol A Biol Sci Med Sci; 2021 Oct; 76(11):1895-1905. PubMed ID: 33406219
[TBL] [Abstract][Full Text] [Related]
11. Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin.
Sierra-Ramirez A; López-Aceituno JL; Costa-Machado LF; Plaza A; Barradas M; Fernandez-Marcos PJ
Aging (Albany NY); 2020 Jun; 12(12):11337-11348. PubMed ID: 32584785
[TBL] [Abstract][Full Text] [Related]
12. Cellular senescence drives age-dependent hepatic steatosis.
Ogrodnik M; Miwa S; Tchkonia T; Tiniakos D; Wilson CL; Lahat A; Day CP; Burt A; Palmer A; Anstee QM; Grellscheid SN; Hoeijmakers JHJ; Barnhoorn S; Mann DA; Bird TG; Vermeij WP; Kirkland JL; Passos JF; von Zglinicki T; Jurk D
Nat Commun; 2017 Jun; 8():15691. PubMed ID: 28608850
[TBL] [Abstract][Full Text] [Related]
13. Senolytic treatment reverses obesity-mediated senescent cell accumulation in the ovary.
Hense JD; Garcia DN; Isola JV; Alvarado-Rincón JA; Zanini BM; Prosczek JB; Stout MB; Mason JB; Walsh PT; Brieño-Enríquez MA; Schadock I; Barros CC; Masternak MM; Schneider A
Geroscience; 2022 Jun; 44(3):1747-1759. PubMed ID: 35460445
[TBL] [Abstract][Full Text] [Related]
14. Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin.
Raffaele M; Kovacovicova K; Frohlich J; Lo Re O; Giallongo S; Oben JA; Faldyna M; Leva L; Giannone AG; Cabibi D; Vinciguerra M
Cell Commun Signal; 2021 Apr; 19(1):44. PubMed ID: 33832488
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
[TBL] [Abstract][Full Text] [Related]
16. Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH.
Bonnet L; Alexandersson I; Baboota RK; Kroon T; Oscarsson J; Smith U; Boucher J
Front Endocrinol (Lausanne); 2022; 13():957616. PubMed ID: 36072934
[TBL] [Abstract][Full Text] [Related]
17. Selective insulin resistance in hepatocyte senescence.
Aravinthan A; Challis B; Shannon N; Hoare M; Heaney J; Alexander GJM
Exp Cell Res; 2015 Feb; 331(1):38-45. PubMed ID: 25263463
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence and its role in white adipose tissue.
Smith U; Li Q; Rydén M; Spalding KL
Int J Obes (Lond); 2021 May; 45(5):934-943. PubMed ID: 33510393
[TBL] [Abstract][Full Text] [Related]
19. Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy.
Kim SR; Puranik AS; Jiang K; Chen X; Zhu XY; Taylor I; Khodadadi-Jamayran A; Lerman A; Hickson LJ; Childs BG; Textor SC; Tchkonia T; Niewold TB; Kirkland JL; Lerman LO
J Am Soc Nephrol; 2021 Aug; 32(8):1987-2004. PubMed ID: 34135081
[TBL] [Abstract][Full Text] [Related]
20. Identification of gingerenone A as a novel senolytic compound.
Moaddel R; Rossi M; Rodriguez S; Munk R; Khadeer M; Abdelmohsen K; Gorospe M; Ferrucci L
PLoS One; 2022; 17(3):e0266135. PubMed ID: 35349590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
